Parallax Volatility Advisers, L.P. Lannett CO Inc Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.47 - $0.87 $11,092 - $20,532	-23,600 Reduced 38.22%	38,152 $22,000
Q1 2022 May 16, 2022	BUY	$0.75 - $1.77 $46,314 - $109,301	61,752 New	61,752 $49,000
Q1 2019 May 15, 2019	SELL	$5.35 - $9.82 $148,730 - $272,996	-27,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.43 - $6.19 $95,354 - $172,082	27,800 New	27,800 $138,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $354,326 - $1.08 Million	-74,595 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $782,412 - $1.03 Million	58,828 Added 373.11%	74,595 $1.01 Million
Q4 2017 Feb 14, 2018	BUY	$19.9 - $29.25 $313,763 - $461,184	15,767	15,767 $366,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.